InsidersTradesSigma
에이프로젠바이오로직스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 에이프로젠바이오로직스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에이프로젠바이오로직스 has logged 13 reports. Market capitalisation: €33.9bn. The latest transaction was filed on 8 May 2026 (Sale). Among the most active insiders: 에이프로젠. The full history is openly available.
13
Insider Decl.
0
Thresholds
€117m
3 ops.
Buy Volume
€680m
9 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 May 2026
Declarations13 total
13 of 13 declarations